Investing.com - BioRestorative Therapies reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that topped expectations.
BioRestorative Therapies announced earnings per share of $-1.28 on revenue of $29.00K. Analysts polled by Investing.com anticipated EPS of $-0.49 on revenue of $0.00.
BioRestorative Therapies shares are down 35% from the beginning of the year and are trading at $2.81 , down-from-52-week-high.
BioRestorative Therapies follows other major Healthcare sector earnings this month
BioRestorative Therapies's report follows an earnings beat by Eli Lilly on Tuesday, November 1, 2022, who reported EPS of $1.98 on revenue of $6.94B, compared to forecasts EPS of $1.91 on revenue of $6.91B.
AbbVie had beat expectations on Friday, October 28, 2022 with third quarter EPS of $3.66 on revenue of $14.81B, compared to forecast for EPS of $3.58 on revenue of $14.93B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar